{"success":true,"data":{"pressRelease":{"id":"133898","rtpr_id":"nGNXbX65Gl","ticker":"MNKD","exchange":"NASDAQ","all_tickers":["MNKD"],"title":"MannKind to Present at Upcoming Investor Conferences","author":"Globe Newswire","published_at":"2026-09-02T12:30:00.623Z","article_body":"DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE)\n-- MannKind Corporation (Nasdaq: MNKD), today announced that members of the\nMannKind management team will present at the following upcoming investor\nconferences:\n\nCantor Global Healthcare Conference (New York, NY)\nFireside Chat, Thursday, September 10, 2026, at 11:30 a.m. ET\n\nH.C. Wainwright 28th Annual Global Investment Conference (New York, NY)\nFireside Chat, Tuesday, September 15, 2026, at 9:30 a.m. ET\n\nLinks to the live audio webcasts of the presentations will be available on\nMannKind Corporation’s website\nat: https://investors.mannkindcorp.com/events-and-presentations. A recorded\nversion will also be available on the website for approximately 90 days\nfollowing the conference.\n\nAbout MannKind \nMannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated\nto transforming chronic disease care through innovative, patient-centric\nsolutions. Focused on cardiometabolic and orphan lung diseases, we develop and\ncommercialize treatments that address serious unmet medical needs, including\ndiabetes, pulmonary hypertension, and fluid overload in heart failure and\nchronic kidney disease.\n\nWith deep expertise in drug-device combinations, MannKind aims to deliver\ntherapies designed to fit seamlessly into daily life.\n\nLearn more at mannkindcorp.com.\n\nContacts:\nInvestor Relations\nKate Miranda\nir@mnkd.com\n\nMedia Relations\nChristie Iacangelo\nmedia@mnkd.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/fc4da88e-772c-44f1-87a9-36ece175bc5b)\n\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNXbX65Gl","title":"MannKind to Present at Upcoming Investor Conferences","author":"Globe Newswire","ticker":"MNKD","created":"2026-09-02T12:30:00.623Z","tickers":["MNKD"],"exchange":"NASDAQ","article_body":"DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE)\n-- MannKind Corporation (Nasdaq: MNKD), today announced that members of the\nMannKind management team will present at the following upcoming investor\nconferences:\n\nCantor Global Healthcare Conference (New York, NY)\nFireside Chat, Thursday, September 10, 2026, at 11:30 a.m. ET\n\nH.C. Wainwright 28th Annual Global Investment Conference (New York, NY)\nFireside Chat, Tuesday, September 15, 2026, at 9:30 a.m. ET\n\nLinks to the live audio webcasts of the presentations will be available on\nMannKind Corporation’s website\nat: https://investors.mannkindcorp.com/events-and-presentations. A recorded\nversion will also be available on the website for approximately 90 days\nfollowing the conference.\n\nAbout MannKind \nMannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated\nto transforming chronic disease care through innovative, patient-centric\nsolutions. Focused on cardiometabolic and orphan lung diseases, we develop and\ncommercialize treatments that address serious unmet medical needs, including\ndiabetes, pulmonary hypertension, and fluid overload in heart failure and\nchronic kidney disease.\n\nWith deep expertise in drug-device combinations, MannKind aims to deliver\ntherapies designed to fit seamlessly into daily life.\n\nLearn more at mannkindcorp.com.\n\nContacts:\nInvestor Relations\nKate Miranda\nir@mnkd.com\n\nMedia Relations\nChristie Iacangelo\nmedia@mnkd.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/fc4da88e-772c-44f1-87a9-36ece175bc5b)\n\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-09-02T12:30:00.71773765Z","server_sent_at_ms":1788352200717},"received_at":"2026-09-02T12:30:00.803Z","source_url":"https://www.globenewswire.com/news-release/2026/09/02/3355137/29517/en/mannkind-to-present-at-upcoming-investor-conferences.html"},"analysis":{"id":"122791","press_release_id":"133898","analysis_json":{"industry":{"label":"Biotechnology","sector":"Health Care"},"redFlags":[],"eventType":"other","narrative":"MannKind management will present fireside chats at two September investor conferences: the Cantor Global Healthcare Conference on September 10, 2026 at 11:30 a.m. ET and the H.C. Wainwright 28th Annual Global Investment Conference on September 15, 2026 at 9:30 a.m. ET, both in New York.\n\nLive audio webcasts will be available on the company's investor relations website, with recorded versions archived for approximately 90 days after each conference.\n\nThe release contains no financial, clinical, or strategic updates and is a routine investor-relations scheduling notice.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine IR scheduling -- suppress posting; note webcast dates in case management offers color on cardiometabolic pipeline."},"keyFigures":{"customDimensions":{"upcoming_presentations":["Cantor Global Healthcare Conference fireside chat, September 10, 2026, 11:30 a.m. ET, New York","H.C. Wainwright 28th Annual Global Investment Conference fireside chat, September 15, 2026, 9:30 a.m. ET, New York"],"webcast_replay_availability":"approximately 90 days"}},"namedEntities":{"people":[{"name":"Kate Miranda","role":"Investor Relations contact"},{"name":"Christie Iacangelo","role":"Media Relations contact"}],"products":[],"companies":[{"name":"MannKind Corporation","ticker":"MNKD","relationship":"issuer"},{"name":"Cantor","relationship":"conference host"},{"name":"H.C. Wainwright","relationship":"conference host"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Routine investor-relations scheduling notice for two fireside chat appearances with no new financial, clinical, or strategic disclosure. Boilerplate corporate announcement with no expected market impact."},"tickerRelevance":{"others":[],"primary":"MNKD"},"globalImportance":10,"audienceRelevance":30,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"mid-small-cap biotech","eventGravity":"routine-IR-scheduling","issuerAuthored":true,"newInformation":false,"householdBrandBoost":false,"retailFavoriteBoost":"moderate (MNKD has a retail following)"}},"event_type":"other","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"MannKind management will present fireside chats at two September investor conferences: the Cantor Global Healthcare Conference on September 10, 2026 at 11:30 a.m. ET and the H.C. Wainwright 28th Annual Global Investment Conference on September 15, 2026 at 9:30 a.m. ET, both in New York.\n\nLive audio webcasts will be available on the company's investor relations website, with recorded versions archived for approximately 90 days after each conference.\n\nThe release contains no financial, clinical, or strategic updates and is a routine investor-relations scheduling notice.","key_figures":{"customDimensions":{"upcoming_presentations":["Cantor Global Healthcare Conference fireside chat, September 10, 2026, 11:30 a.m. ET, New York","H.C. Wainwright 28th Annual Global Investment Conference fireside chat, September 15, 2026, 9:30 a.m. ET, New York"],"webcast_replay_availability":"approximately 90 days"}},"named_entities":{"people":[{"name":"Kate Miranda","role":"Investor Relations contact"},{"name":"Christie Iacangelo","role":"Media Relations contact"}],"products":[],"companies":[{"name":"MannKind Corporation","ticker":"MNKD","relationship":"issuer"},{"name":"Cantor","relationship":"conference host"},{"name":"H.C. Wainwright","relationship":"conference host"}],"dollarAmounts":[]},"model_name":"glm-4.7","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-09-02T15:03:00.021Z","global_importance":10,"audience_relevance":30,"importance_components":{"tickerTier":"mid-small-cap biotech","eventGravity":"routine-IR-scheduling","issuerAuthored":true,"newInformation":false,"householdBrandBoost":false,"retailFavoriteBoost":"moderate (MNKD has a retail following)"}},"durationMs":339909,"modelName":"glm-4.7"}}